CDSCO Panel grants Cadila Healthcare's protocol amendment for Saroglitazar Tablets Dr. Divya Colin5 Feb 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major ....
Glenmark Gets CDSCO panel nod for Phase IV CT of Fosnetupitant, Palanosetron FDC drug Dr. Divya Colin5 Feb 2023 5:00 PM ISTNew Delhi: Pharmaceutical major Glenmark Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under Central Drug...
Natco Pharma gets 2 observations from USFDA for Vizag facility Ruchika Sharma5 Feb 2023 1:00 PM ISTHyderabad: Natco Pharma Limited has announced the completion of a regulatory inspection from the United States Food and Drug Administration (USFDA)...
Demand for affordable Indian generic vaccines skyrocket in China amid COVID surge Ruchika Sharma5 Feb 2023 11:00 AM ISTBeijing: The world observed a brief pause in the Covid-19 insurgence after taking the vaccines, but it did not last for long. China reported a spike...
Japan's Takeda Pharma profit slips 13 percent, pipeline bolsters outlook Ruchika Sharma5 Feb 2023 10:00 AM ISTThe company said core operating profit, which strips out non-recurring items, increased 26 percent in the nine-month period.
USFDA nod to Takeda TAKHZYRO to prevent Hereditary Angioedema attacks in children 2 years of age and older Ruchika Sharma4 Feb 2023 1:15 PM ISTHereditary angioedema (HAE) is a rare genetic disorder that results in recurring attacks of edema - swelling - in various parts of the body, including...
India to spend USD 79.6 million to strengthen drug regulatory system: Health Minister Ruchika Sharma4 Feb 2023 1:15 PM ISTMandaviya said the federal government has allocated funds to his ministry for measures including setting up new drug testing laboratories and...
Gilead Sciences secures USFDA okay for Trodelvy for pre-treated HR+/HER2- Metastatic Breast Cancer Ruchika Sharma4 Feb 2023 11:37 AM ISTTrodelvy (sacituzumab govitecan-hziy) is a first-in-class Trop-2 directed antibody-drug conjugate.
Sanofi forecasts moderate profit growth on eczema drug Dupixent demand Ruchika Sharma4 Feb 2023 10:00 AM ISTParis: Sanofi forecast moderate earnings growth that undershot expectations, saying demand for bestselling asthma and eczema drug Dupixent...
Central, state teams on way to Global Pharma Healthcare plant after firm recalls eye drop linked to vision loss in US Ruchika Sharma4 Feb 2023 9:45 AM ISTThe USFDA noted that the "use of contaminated Artificial Tears can result in the risk of eye infections that could result in blindness".
Finance Minister announces launch of new programme to promote research in pharma Ruchika Sharma3 Feb 2023 5:28 PM ISTCharu Sehgal, Partner, Deloitte India said," The announcement of providing investment and setting up centres of excellence to promote research and...
Zydus Lifesciences consolidated net profit rises 24.48 percent YoY to Rs 622.9 crore in Q3 Ruchika Sharma3 Feb 2023 3:28 PM ISTTotal expenses in the third quarter were higher at Rs 3,620.7 crore, as compared to Rs 3,096.3 crore in the corresponding period last fiscal.
